that than little on some COVID-XX and seeing operating quarterly our call. call pandemic for discussing of of a I will the with our these conference be by we business, you, financial will the different Bill. the today’s will that format The thoughts to strategy thank begin up Kathryn are McKenzie then detailed growing our results, more impact Well, a typical difficult on response review and the wrap business for quarter provide and I times. in one will our
of We have time answers. questions will course for and then
COVID-XX Let’s begin a pandemic. our with response the discussion of to
going challenging Fortunately, of we were position in COVID-XX. good relatively time into this a
Our this believe strongly balance of capacity. business is momentum We both the momentum borrowing positive crisis at out going have that volume revenue expectations of will well. positive tracking we strong, prior this it’s to or sheet solid profitable and the virus. come with above onset as with a had available into we crisis, with and We
for patients. return schedules cancer gradually growth to that critical oncologists are treatment and patient expect our seek and is normal levels. cancer and We fully patients rates their normal resume services more when it hospitals volumes to will Our safe test again, for when
been has for first secure patients. thereby well-being the cancer our our and In of to employees of crisis, principle testing maintain oncology the safety to continuity guiding critical the responding our and to
relatively also emerge this desire by influenced from crisis position. a was response our Our to in competitive superior
workforce, on and the As strengthen actions short-term competitiveness. designed invest on to implementing long-term our initiatives or our we a rather than focus focused culture result, strategies furloughs, and layoffs strengthen to our in
employees an time space shifts emergency the To employee personally to for and paid facilities, policy early protect put travel adjusted who on, visitors laboratory our virus. our and affected employees, de-densified off people, restricted between restricted distance we to and were laboratories by our facilities, implemented
that. for environment implemented training remote quickly a and provided support and also work We
of productively feedback a our well in comprehensive two-thirds the For to from extensively our well and We employee governmental communicated home. past actions weeks, employees response several of as with implemented had medical, working array as over we employees guidance. and have scientific
also ensure we cases, added inventory worked. actions In to we adequate to chain that We supply These have continue our testing. managing carefully have supply have months been to levels. our certain of inventory
our have of or quality throughout all with able main without remained interruption turnaround continue Importantly, our this and all excellent delay. been lab to we and facilities crisis open time have services of testing
We have also to doing responded country. part help by our our
company, other oncology and some are dedicated number quickly. in offering expertise an testing are testing our we ramping strong we now are capabilities. develop extremely of the COVID-XX molecular a and have experts commercial and to we laboratories, have test capacity Although R&D Like do laboratory PCR up
perform week, we there to that day. capacity over will If the significantly ramp COVID-XX per tests higher. can have is quickly X,XXX demand, PCR up we Within
know too other We also out for serology feel point, COVID-XX soon. early have impact the back this us we that estimate test because of instrumentation the should the offer right it’s test ready COVID-XX from have able invested is thing to and critical to to A reached to is At help organizations help this do people in and get We equipment to number we work. offering. the be safely to financial testing doing do. be it to and are
very have COVID-XX. good team taken feels actions about we the in that response to Overall, our
had an has impact on pandemic our business. the However,
to basis. was April, year-over-year, has volume test down it with strong for a was by X% volume more appeared and because in slightly it two up quite week-over-week XX% test clinical last of the weeks In compared most March, quarter the XX%. for XX% clinical on of Although and down it the declined last stabilize quarter, only year, approximately full was although was between
We COVID-XX believe were available. of were this is have practices whom reduced reluctant Cancer patient condition. devoted many regions some reduced resources of country, to surgeries their and immune of hospitals postponed if a they urgent and decline oncology In hours operation understandable. as needs. even physicians appointments. volume the The temporary is preparations many cancelled to they compromised see patients, systems, Similarly, or
an that been COVID-XX. of have us delayed also some have in We have Services to told Pharma seen Division they our contracts certain sites that projects of account our as signed unable trials train due staff. business. trials XX% enrollment to trials typically as revenue for on are onsite about clinical start typically our new impact visiting clinical involves Clinical backlog to Sponsors effort
pandemic support that half work business by other of The far. been research and our so affected has Pharma is in largely development Services pharma of the and companies’ not
encouragingly, on Pharma new amount Services and an are we we seen not Significantly the have impact signing. of contracts
though, quarter second have contracts of not million companies, employees signed lot $XX all an situation. In new the highest employee business Like most we has of immune time. to unprecedented reduced this additional or bookings fact, furloughed the of of levels. during been NeoGenomics we a not our quarter, for our Unlike companies impacts
it our Although and culture. may our short-term people reduce profitability, are investing we in
training, critical cash to laboratories development of on a small even time. working of We more in employees are and those during one are that providing bonus more our this appreciation the frontline
our an employees and strong we the strength responding level are very is as as our strong Our of believe team positively and A company. competitive employee culture ever. of important engagement is
to proud to time them. and as this quality, employees’ testing continued to critical I hats patients am service, off think NeoGenomics cancer services you as about customer my to have would I turnaround response they this unprecedented provide crisis, with be situation. Throughout our excellent
I Kathryn of our financial discuss quarter to Financial will the the of over McKenzie, results. to details call Chief now one Officer, turn some